piracetam has been researched along with cinnarizine in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Spagnoli, A; Tognoni, G | 1 |
Milanova, D; Nikolov, R; Nikolova, M | 1 |
Grünberger, J; Saletu, B | 1 |
Artemova, IIu; Batysheva, TT; Boĭko, AN; Es'kina, TA; Ganzhula, PA; Kabanov, AA; Shchukin, AI; Sheliakina, LA; Vdovichenko, TV; Volovets, SA | 1 |
Batysheva, TT; Boiko, AN; Gusev, EI; Manevich, TM; Matvievskaya, OV | 1 |
Arabkhanova, MA; Gusev, EI; Iasamanova, AN; Kabanov, AA; Kolesnikova, TI; Martynov, MIu; Pyshkina, LI | 1 |
Bodrova, TV; Lobzin, SV; Vasilenko, AV | 1 |
Belavina, GR; Gusev, VV; Levin, IaI; Markin, SP; Parfenov, VA; Starchina, IuA; Vakhnina, NV | 1 |
Kiparisov, MA; Stroganova, IM | 1 |
Chuprina, SE | 1 |
Batysheva, TT; Boĭko, AN; Kamchatnov, PR; Popova, NF; Riabukhina, OV; Zaĭtsev, KA | 1 |
Braunbeck, T; Broschard, TH; Huebler, N; Strecker, R; Weigt, S | 1 |
Gromova, OA; Torshin, IY | 1 |
Abbas, AEF; Attia, KAM; Eid, SM; El-Olemy, A; Serag, A | 1 |
1 review(s) available for piracetam and cinnarizine
Article | Year |
---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate Choline; Dementia; Dihydroergotoxine; Humans; Middle Aged; Nafronyl; Pentoxifylline; Piracetam; Vasodilator Agents; Vincamine | 1983 |
5 trial(s) available for piracetam and cinnarizine
Article | Year |
---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate Choline; Dementia; Dihydroergotoxine; Humans; Middle Aged; Nafronyl; Pentoxifylline; Piracetam; Vasodilator Agents; Vincamine | 1983 |
Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.
Topics: Adult; Age Factors; Aged; Benzamides; Brain; Cinnarizine; Clinical Trials as Topic; Dihydroergotoxine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Electroencephalography; Female; Hexobendine; Humans; Isoxsuprine; Levetiracetam; Male; Middle Aged; Nicergoline; Piracetam; Psychotropic Drugs; Theophylline; Time Factors | 1980 |
[Phezam efficacy in patients with chronic cerebral ischemic disease].
Topics: Aged; Brain; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Chronic Disease; Cinnarizine; Drug Combinations; Female; Humans; Male; Middle Aged; Nootropic Agents; Piracetam | 2005 |
Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage.
Topics: Adult; Brain Injuries; Calcium Channel Blockers; Cinnarizine; Drug Therapy, Combination; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Piracetam; Severity of Illness Index | 2007 |
[Omaron in the complex treatment of patients with multiple sclerosis].
Topics: Adult; Cinnarizine; Drug Combinations; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Piracetam; Treatment Outcome; Young Adult | 2010 |
12 other study(ies) available for piracetam and cinnarizine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Anti-hypoxic effect of piracetam and its interaction with prostacyclin.
Topics: Animals; Atmospheric Pressure; Cinnarizine; Drug Synergism; Epoprostenol; Female; Hypoxia; Ischemia; Mice; Mice, Inbred Strains; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Vinca Alkaloids | 1984 |
[Phezam in combined therapy of ischemic stroke].
Topics: Administration, Oral; Blood Flow Velocity; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Cinnarizine; Cognition; Drug Combinations; Follow-Up Studies; Humans; Middle Aged; Piracetam; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2008 |
[Omaron in the treatment of vertebrobasilar insufficiency].
Topics: Administration, Oral; Adult; Aged; Calcium Channel Blockers; Cinnarizine; Dose-Response Relationship, Drug; Drug Combinations; Electroencephalography; Female; Follow-Up Studies; Hemodynamics; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroprotective Agents; Piracetam; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vertebrobasilar Insufficiency; Young Adult | 2009 |
[Use of omaron in patients with post-stroke cognitive disorders].
Topics: Administration, Oral; Aged; Cinnarizine; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Male; Middle Aged; Neuroprotective Agents; Piracetam; Stroke; Treatment Outcome | 2009 |
[Omaron in the restorative treatment of patients with chronic cerebrovascular insufficiency].
Topics: Administration, Oral; Atherosclerosis; Brain Ischemia; Calcium Channel Blockers; Carotid Arteries; Cerebrovascular Circulation; Chronic Disease; Cinnarizine; Drug Combinations; Drug Synergism; Female; Follow-Up Studies; Humans; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Male; Middle Aged; Neuroprotective Agents; Piracetam; Recovery of Function; Treatment Outcome; Ultrasonography, Doppler; Vertebral Artery | 2010 |
[Omaron in the rehabilitation of post stroke outpatients].
Topics: Calcium Channel Blockers; Cinnarizine; Drug Combinations; Humans; Neuroprotective Agents; Piracetam; Stroke; Stroke Rehabilitation | 2010 |
Zebrafish (Danio rerio) embryos as a model for testing proteratogens.
Topics: 2-Acetylaminofluorene; Aflatoxin B1; Animals; Carbamazepine; Cinnarizine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Ifosfamide; Mutagenicity Tests; Ovum; Piracetam; Tegafur; Teratogens; Thiotepa; Trimethadione; Zebrafish | 2011 |
[Comparative chemoreactome analysis of the synergism of vinpocetine, piracetam, and cinnarizine molecules].
Topics: Animals; Cinnarizine; Mice; Nootropic Agents; Piracetam; Rats; Vinca Alkaloids | 2021 |
Environmentally sustainable DRS-FTIR probe assisted by chemometric tools for quality control analysis of cinnarizine and piracetam having diverged concentration ranges: Validation, greenness, and whiteness studies.
Topics: Chemometrics; Cinnarizine; Least-Squares Analysis; Piracetam; Quality Control; Spectroscopy, Fourier Transform Infrared | 2023 |